Key terms

About RCUS

Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest RCUS news

Apr 12 6:50am ET Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC) and Arcus Biosciences (RCUS) Feb 25 11:29pm ET Evaluating Arcus Biosciences’ Casdatifan Potential and Strategic Position in RCC Treatment Landscape Feb 22 7:11am ET Analysts Offer Insights on Healthcare Companies: Crispr Therapeutics AG (CRSP), Arcus Biosciences (RCUS) and United Therapeutics (UTHR) Feb 22 5:40am ET Analysts Offer Insights on Healthcare Companies: Arcus Biosciences (RCUS), Ionis Pharmaceuticals (IONS) and Icon (ICLR) Feb 22 5:07am ET Barclays Sticks to Its Buy Rating for Arcus Biosciences (RCUS) Feb 21 4:11pm ET Arcus Biosciences reports Q4 EPS ($1.08), consensus ($1.02) Feb 08 6:31am ET Analysts Offer Insights on Healthcare Companies: McKesson (MCK), Arcus Biosciences (RCUS) and Neurocrine (NBIX) Feb 02 11:07am ET Biotech Alert: Searches spiking for these stocks today Feb 01 11:24am ET Biotech Alert: Searches spiking for these stocks today Jan 30 8:38am ET Arcus Biosciences price target lowered to $30 from $36 at Wedbush Jan 30 6:36am ET Arcus Biosciences price target lowered to $42 from $51 at Mizuho Jan 29 5:06pm ET Gilead raises ownership stake in Arcus Biosciences to 33%, adds board seat Jan 24 1:44am ET Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT), Arcus Biosciences (RCUS) and Zai Lab (ZLAB) Jan 24 1:40am ET Optimistic Buy Rating for Arcus Biosciences Amid Promising Clinical Data on Quemliclustat Jan 23 4:04am ET Analysts Offer Insights on Healthcare Companies: Citius Pharmaceuticals (CTXR), Arcus Biosciences (RCUS) and Masimo (MASI) Jan 16 5:03pm ET Arcus Biosciences announces ‘promising’ ARC-8 Phase 1b study data

No recent news articles are available for RCUS

No recent press releases are available for RCUS

RCUS Financials

1-year income & revenue

Key terms

RCUS Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

RCUS Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms